Share:
Published on Jul 18, 2025
STSK Investment Group and Zentrogene Bioscience Laboratory Explore Strategic Collaboration
On Friday, July 18, 2025, STSK Investment Group, led by Mr. SOK Vatanak, Chief Investment Officer, held a meeting with the management of Zentrogene Cambodia to explore potential collaboration, in the space of advanced medical laboratory.

Dr. YANG Gongda, Zentrogene's CEO, expressed strong enthusiasm for advancing the partnership, emphasizing the shared vision for innovation and sustainable growth within Cambodia’s biotechnology sector. Both parties recognized the potential to leverage complementary strengths—STSK’s investment expertise and Zentrogene’s pioneering research—to drive impactful outcomes. More round of discussions to follow to determine a formal form of collaboration in months to come.

